Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement.
| Market Cap | 768.693 Million | Shares Outstanding | 61.545 Million | Avg 30-day Volume | 672.842 Thousand |
| P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.31 |
| Price to Revenue | 9.4038 | Debt to Equity | 0.3525 | EBITDA | -38.74 Million |
| Price to Book Value | 10.4706 | Operating Margin | -24.9401 | Enterprise Value | 1.484 Billion |
| Current Ratio | 6.598 | EPS Growth | 0 | Quick Ratio | 5.553 |
| 1 Yr BETA | 0.992 | 52-week High/Low | 27.97 / 11.85 | Profit Margin | -25.3156 |
| Operating Cash Flow Growth | -24.6958 | Free Cash Flow to Firm (FCFF) TTM | -69.748 Million | Free Cash Flow to Equity (FCFE) TTM | -126.592 Million |
| Altman Z-Score | 9.7578 | ||||
| Earnings Report | 2023-11-07 |
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
0 | 2023-06-02 | 15 | |
|
347,348 | 2023-05-23 | 1 | |
|
907,753 | 2023-05-23 | 12 | |
|
5,048 | 2023-05-23 | 1 | |
|
5,585 | 2023-05-23 | 1 | |
|
5,585 | 2023-05-23 | 1 | |
|
6,235 | 2023-05-23 | 1 | |
|
6,235 | 2023-05-23 | 1 | |
|
SCANLAN SEAN F. CHIEF INNOVATION OFFICER |
|
32,395 | 2023-05-16 | 6 |
|
2,289,065 | 2023-04-28 | 7 | |
|
1,513,064 | 2023-03-15 | 7 | |
|
30,914 | 2023-03-15 | 4 | |
|
HAIR MARK CHIEF FINANCIAL OFFICER |
|
102,445 | 2023-03-09 | 1 |
|
TREACE JOHN T. CHIEF EXECUTIVE OFFER |
|
16,485,364 | 2023-03-09 | 3 |
|
BERUTTI AARON SR. VP, SALES |
|
42,842 | 2023-03-09 | 2 |
|
ELDER SCOT MICHAEL *SEE "REMARKS" |
|
49,921 | 2023-03-09 | 3 |
|
2,231,606 | 2022-05-09 | 0 | |
|
FRIAS JAIME A. CHIEF LEGAL OFFICER |
|
276,208 | 2022-03-08 | 0 |
|
LUBBEN TERRY W. SVP, OPERATIONS |
|
31,650 | 2022-03-08 | 0 |
|
FERGUSON JOE W. SVP, RESEARCH & DEVELOPMENT |
|
754,325 | 2021-10-06 | 0 |
|
RAJHANSA DIPAK SVP, SALES |
|
167,188 | 2021-04-22 | 0 |
|
COX NEIL A CFO |
|
680,000 | 2009-06-30 | 0 |
|
HARRIS JOHN N PRESIDENT |
|
680,000 | 2009-06-30 | 0 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|---|---|---|---|
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 22:15:04 UTC | 4.9119 | 0.4081 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 21:45:04 UTC | 4.9119 | 0.4081 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 21:15:04 UTC | 4.9119 | 0.4081 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 20:45:04 UTC | 4.9119 | 0.4081 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 20:15:04 UTC | 4.9119 | 0.4081 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 19:45:04 UTC | 4.9119 | 0.4081 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 19:15:04 UTC | 4.9119 | 0.4081 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 18:45:05 UTC | 4.9119 | 0.4081 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 18:15:03 UTC | 0.0 | 0.0 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 17:45:04 UTC | 4.9119 | 0.4081 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 17:15:04 UTC | 4.9119 | 0.4081 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 16:45:04 UTC | 4.9119 | 0.4081 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 16:15:04 UTC | 4.9119 | 0.4081 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 15:45:04 UTC | 4.9119 | 0.4081 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 15:15:05 UTC | 4.9119 | 0.4081 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 14:45:04 UTC | 4.9119 | 0.4081 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 14:15:04 UTC | 4.9119 | 0.4081 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 13:45:03 UTC | 5.0201 | 0.2999 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 13:15:04 UTC | 5.0201 | 0.2999 | 1000000 |
| TREACE MEDICAL CONCEPTS INC TMCI | 2023-10-03 12:45:04 UTC | 5.0201 | 0.2999 | 1000000 |
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
